10-Q: Western Acquisition Ventures Corp. Reports Q1 2024 Results, Navigates Business Combination and Compliance Challenges

Western Acquisition Ventures Corp. reported a net income of $408,380 for the first quarter of 2024, while also addressing ongoing challenges related to its business combination and Nasdaq listing compliance.

Summary

• Western Acquisition Ventures Corp., a blank check company, reported a net income of $408,380 for the three months ended March 31, 2024, a significant turnaround from a net loss of $171,611 in the same period of 2023.
• The company's financial performance was primarily influenced by a $665,116 change in the fair value of a forward purchase agreement, which was subsequently terminated, and offset by $256,736 in operating expenses.
• The company has been focused on completing a business combination with Cycurion Inc., and has extended the deadline to complete the merger to October 11, 2024.
• The company has faced challenges with Nasdaq listing requirements, including minimum public float and board independence, and is working to regain compliance.
• The company has also identified a material weakness in its internal controls over financial reporting related to the timely filing of its quarterly report.
• The company has a working capital deficit of $2,782,776 as of March 31, 2024, and is relying on loans and investments from its sponsor and related parties to meet its working capital needs.
• The company has redeemed 31,143 shares of common stock for $327,375 during the quarter.
• The company has a loan payable to Cycurion of $554,269 with a 5% interest rate, due on the earlier of the business combination or October 11, 2024.

Sentiment

Score: 4

Explanation: The document presents a mixed picture with some positive financial results offset by significant challenges and risks. The company's ability to continue as a going concern is in doubt, and there are concerns about its compliance with Nasdaq listing requirements and internal controls. The sentiment is therefore negative overall.

Positives

• The company achieved a net income of $408,380 in Q1 2024, a significant improvement from the net loss in the same period of the previous year.
• The change in fair value of the forward purchase agreement resulted in a substantial gain of $665,116.
• The company has secured an extension to complete its business combination with Cycurion, providing additional time to finalize the merger.

Negatives

• The company has a significant working capital deficit of $2,782,776.
• The company is facing challenges in maintaining compliance with Nasdaq listing requirements.
• The company identified a material weakness in its internal controls over financial reporting.
• The company has a loan payable to Cycurion of $554,269 with a 5% interest rate, which is due on the earlier of the business combination or October 11, 2024.

Risks

• The company's ability to continue as a going concern is in doubt if it cannot complete a business combination by October 11, 2024.
• The company is reliant on loans and investments from its sponsor and related parties to meet its working capital needs, and may not be able to obtain additional financing.
• Failure to regain compliance with Nasdaq listing requirements could result in the delisting of the company's securities.
• The company's internal control weaknesses could lead to inaccurate financial reporting and loss of investor confidence.
• The company is subject to a 1% excise tax on share repurchases, which could reduce available cash.
• The business combination with Cycurion is not guaranteed and may be terminated under certain conditions.

Future Outlook

The company is focused on completing its business combination with Cycurion by October 11, 2024, and is working to regain compliance with Nasdaq listing requirements. The company's ability to continue as a going concern is dependent on the successful completion of the business combination.

Management Comments

• Management has determined that the mandatory liquidation and subsequent dissolution, should the Company be unable to complete a Business Combination, raises substantial doubt about the Company's ability to continue as a going concern.
• Management is actively engaged in efforts to regain compliance with the requirements set forth in Nasdaq Listing Rule 5605 and plans to regain compliance within the Cure Period provided by Nasdaq.

Industry Context

The document reflects the challenges faced by many SPACs in the current market, including difficulties in completing business combinations, maintaining listing compliance, and managing financial resources. The company's situation is not unique, as many SPACs are facing similar pressures to find suitable targets and complete mergers within their allotted timeframes.

Comparison to Industry Standards

• The company's financial performance is mixed compared to industry standards for SPACs. While the company achieved a net income for the quarter, many SPACs are still in the pre-revenue stage and are incurring losses.
• The company's working capital deficit is a concern, as many SPACs rely on their trust accounts and sponsor funding to cover operating expenses.
• The company's challenges with Nasdaq listing compliance are not uncommon, as many SPACs struggle to maintain the required minimum public float and board independence.
• The company's reliance on loans from related parties is also a common practice among SPACs, but it can create potential conflicts of interest.
• The company's forward purchase agreement is a unique arrangement, and the termination of the agreement resulted in a significant gain for the quarter.

Related Party Transactions

• The company has a loan payable to Cycurion of $554,269 with a 5% interest rate.
• The company is relying on loans and investments from its sponsor and related parties to meet its working capital needs.

Stakeholder Impact

• Shareholders face the risk of losing their investment if the company fails to complete a business combination by October 11, 2024.
• Employees may be impacted by the uncertainty surrounding the company's future.
• Customers and suppliers of the target company, Cycurion, may be affected by the outcome of the business combination.
• Creditors of the company face the risk of not being repaid if the company is liquidated.

Next Steps

• The company needs to complete its business combination with Cycurion by October 11, 2024.
• The company needs to regain compliance with Nasdaq listing requirements.
• The company needs to remediate the material weakness in its internal controls over financial reporting.
• The company needs to secure additional funding to meet its working capital needs.

Key Dates

Keywords

Business Combination, SPAC, Merger, Cycurion, Nasdaq, Financial Reporting, Internal Controls, Redemption, Working Capital, Forward Purchase Agreement